Correction: Price, amount and settlement date corrected. In relation to Landsbankinn’s covered bond auction yesterday, was a covered bond exchange…
Half-Year Report - RIAS A/S Attachment Half-Year report for RIAS signed 2025-05-14
SINGAPORE, May 14, 2025 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced the pricing of…
Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still…
-- Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data anticipated…
Three Legged Cross, Dorset, May 14, 2025 (GLOBE NEWSWIRE) -- FlexiHeat UK, a leading provider of high-efficiency heating solutions, is…
Cleckheaton, West Yorkshire, May 14, 2025 (GLOBE NEWSWIRE) -- ComfoRest, a leading bed company offering customers a range of high-quality,…
ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2…
Actively enrolling nAMD patients in a Phase 1 trial of TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide…
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage…
This website uses cookies.